Human dopamine transporter gene variation: Effects of protein coding variants V55A and V382A on expression and uptake activities

Zhicheng Lin, George R. Uhl

Research output: Contribution to journalArticle

Abstract

The human dopamine transporter (DAT, SLC6A3) is an important 15 exon gene for dopamine neurotransmission and dopamine recycling. Common exon 15 variable number tandem repeat variants can be associated with attention deficit/hyperactivity disorder. Rarer single nucleotide polymorphisms produce missense variants including V55A and V382A. We now report studies of the functional influences of these DAT protein-coding variants. In COS cell transient-expression assays, V382A displays about half of the dopamine uptake velocity Vmax and cocaine analog binding Bmax values of wildtype DAT. V382A lowers dopamine's potency in inhibiting cocaine analog binding by six-fold. Cells expressing V382A or mixtures of V382A and wildtype DAT both display reduced plasma membrane and increased perinuclear expression, consistent with dominant effects of V328A on expression. V55A expresses normally but reveals a 1.7-fold-lower Km for dopamine uptake. Individuals with these human DAT protein variants could display altered dopamine systems.

Original languageEnglish (US)
Pages (from-to)159-168
Number of pages10
JournalPharmacogenomics Journal
Volume3
Issue number3
DOIs
StatePublished - 2003
Externally publishedYes

Fingerprint

Dopamine Plasma Membrane Transport Proteins
Dopamine
Genes
Proteins
Cocaine
Exons
Minisatellite Repeats
COS Cells
Recycling
Attention Deficit Disorder with Hyperactivity
Synaptic Transmission
Single Nucleotide Polymorphism
Cell Membrane

Keywords

  • Cocaine affinity
  • Dominant negative
  • Dopamine transporter (DAT)
  • Dopamine uptake
  • Human variants
  • Intracellular expression

ASJC Scopus subject areas

  • Pharmacology
  • Molecular Medicine
  • Genetics

Cite this

Human dopamine transporter gene variation : Effects of protein coding variants V55A and V382A on expression and uptake activities. / Lin, Zhicheng; Uhl, George R.

In: Pharmacogenomics Journal, Vol. 3, No. 3, 2003, p. 159-168.

Research output: Contribution to journalArticle

@article{2316a51cd5564aa98df3d1e4d0d6d1fc,
title = "Human dopamine transporter gene variation: Effects of protein coding variants V55A and V382A on expression and uptake activities",
abstract = "The human dopamine transporter (DAT, SLC6A3) is an important 15 exon gene for dopamine neurotransmission and dopamine recycling. Common exon 15 variable number tandem repeat variants can be associated with attention deficit/hyperactivity disorder. Rarer single nucleotide polymorphisms produce missense variants including V55A and V382A. We now report studies of the functional influences of these DAT protein-coding variants. In COS cell transient-expression assays, V382A displays about half of the dopamine uptake velocity Vmax and cocaine analog binding Bmax values of wildtype DAT. V382A lowers dopamine's potency in inhibiting cocaine analog binding by six-fold. Cells expressing V382A or mixtures of V382A and wildtype DAT both display reduced plasma membrane and increased perinuclear expression, consistent with dominant effects of V328A on expression. V55A expresses normally but reveals a 1.7-fold-lower Km for dopamine uptake. Individuals with these human DAT protein variants could display altered dopamine systems.",
keywords = "Cocaine affinity, Dominant negative, Dopamine transporter (DAT), Dopamine uptake, Human variants, Intracellular expression",
author = "Zhicheng Lin and Uhl, {George R.}",
year = "2003",
doi = "10.1038/sj.tpj.6500169",
language = "English (US)",
volume = "3",
pages = "159--168",
journal = "Pharmacogenomics Journal",
issn = "1470-269X",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - Human dopamine transporter gene variation

T2 - Effects of protein coding variants V55A and V382A on expression and uptake activities

AU - Lin, Zhicheng

AU - Uhl, George R.

PY - 2003

Y1 - 2003

N2 - The human dopamine transporter (DAT, SLC6A3) is an important 15 exon gene for dopamine neurotransmission and dopamine recycling. Common exon 15 variable number tandem repeat variants can be associated with attention deficit/hyperactivity disorder. Rarer single nucleotide polymorphisms produce missense variants including V55A and V382A. We now report studies of the functional influences of these DAT protein-coding variants. In COS cell transient-expression assays, V382A displays about half of the dopamine uptake velocity Vmax and cocaine analog binding Bmax values of wildtype DAT. V382A lowers dopamine's potency in inhibiting cocaine analog binding by six-fold. Cells expressing V382A or mixtures of V382A and wildtype DAT both display reduced plasma membrane and increased perinuclear expression, consistent with dominant effects of V328A on expression. V55A expresses normally but reveals a 1.7-fold-lower Km for dopamine uptake. Individuals with these human DAT protein variants could display altered dopamine systems.

AB - The human dopamine transporter (DAT, SLC6A3) is an important 15 exon gene for dopamine neurotransmission and dopamine recycling. Common exon 15 variable number tandem repeat variants can be associated with attention deficit/hyperactivity disorder. Rarer single nucleotide polymorphisms produce missense variants including V55A and V382A. We now report studies of the functional influences of these DAT protein-coding variants. In COS cell transient-expression assays, V382A displays about half of the dopamine uptake velocity Vmax and cocaine analog binding Bmax values of wildtype DAT. V382A lowers dopamine's potency in inhibiting cocaine analog binding by six-fold. Cells expressing V382A or mixtures of V382A and wildtype DAT both display reduced plasma membrane and increased perinuclear expression, consistent with dominant effects of V328A on expression. V55A expresses normally but reveals a 1.7-fold-lower Km for dopamine uptake. Individuals with these human DAT protein variants could display altered dopamine systems.

KW - Cocaine affinity

KW - Dominant negative

KW - Dopamine transporter (DAT)

KW - Dopamine uptake

KW - Human variants

KW - Intracellular expression

UR - http://www.scopus.com/inward/record.url?scp=0037481699&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037481699&partnerID=8YFLogxK

U2 - 10.1038/sj.tpj.6500169

DO - 10.1038/sj.tpj.6500169

M3 - Article

C2 - 12815364

AN - SCOPUS:0037481699

VL - 3

SP - 159

EP - 168

JO - Pharmacogenomics Journal

JF - Pharmacogenomics Journal

SN - 1470-269X

IS - 3

ER -